Erectile Dysfunction Class Labeling Does Not Assert Causal Link To Vision Loss
This article was originally published in The Pink Sheet Daily
Executive Summary
Labeling revisions for Viagra, Levitra and Cialis will add information about NAION adverse events, but states that “it is not possible to determine whether these events are related directly to the use of PDE5 inhibitors or to other factors.”